Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.27
+0.21 (2.61%)
Nov 9, 2026, 9:51 AM EST - Market open
Immix Biopharma Employees
Immix Biopharma had 21 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Immix Biopharma the 38,234th largest employer in the world and 5,462nd in the United States.
Employees
21
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,900,820
Market Cap
685.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | 0 | - | 21 | 0 |
| Dec 31, 2024 | 21 | 4 | 23.53% | 18 | 3 |
| Dec 31, 2023 | 17 | 6 | 54.55% | 14 | 3 |
| Dec 31, 2022 | 11 | 9 | 450.00% | 9 | 2 |
| Dec 31, 2021 | 2 | - | - | 2 | 0 |
| Sep 30, 2021 | 2 | - | - | 2 | 0 |
| Jun 30, 2021 | 2 | - | - | 2 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Wave Life Sciences | 317 |
| Kura Oncology | 260 |
| 4D Molecular Therapeutics | 196 |
| Aura Biosciences | 113 |
| Adlai Nortye Group | 109 |
| Helus Pharma | 100 |
| ArriVent BioPharma | 77 |
| Zevra Therapeutics | 61 |
IMMX News
- 5 days ago - Immix Biopharma's NXC-201 NEXICART-2 Interim Clinical Trial Results Selected for Oral Presentation at ASH 2026 - GlobeNewsWire
- 11 days ago - Immix Biopharma price target lowered to $23 from $26 at Mizuho - TheFly
- 20 days ago - Immix Biopharma price target raised to $20 from $19 at Morgan Stanley - TheFly
- 4 weeks ago - Immix Biopharma Slides: Investor presentation - Filings
- 5 weeks ago - Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - Immix Biopharma price target raised to $30 from $27 at BofA - TheFly
- 5 weeks ago - Immix Biopharma Transcript: Study result - Transcripts